| Literature DB >> 35812349 |
Yajing Zhang1, Yan Huang1, Rong Chen1, Shulin Chen1, Xiaoying Lü1.
Abstract
The aim of this article was to study the toxicity mechanism of nickel ions (Ni2+) on L929 cells by combining proteomics and metabolomics. First, iTRAQ-based proteomics and LC/MS metabolomics analyses were used to determine the protein and metabolite expression profiles in L929 cells after treatment with 100 μM Ni2+ for 12, 24 and 48 h. A total of 177, 2191 and 2109 proteins and 40, 60 and 74 metabolites were found to be differentially expressed. Then, the metabolic pathways in which both differentially expressed proteins and metabolites were involved were identified, and three pathways with proteins and metabolites showing upstream and downstream relationships were affected at all three time points. Furthermore, the protein-metabolite-metabolic pathway network was constructed, and two important metabolic pathways involving 4 metabolites and 17 proteins were identified. Finally, the functions of the important screened metabolic pathways, metabolites and proteins were investigated and experimentally verified. Ni2+ mainly affected the expression of upstream proteins in the glutathione metabolic pathway and the arginine and proline metabolic pathway, which further regulated the synthesis of downstream metabolites, reduced the antioxidant capacity of cells, increased the level of superoxide anions and the ratio of GSSG to GSH, led to oxidative stress, affected energy metabolism and induced apoptosis.Entities:
Keywords: metabolomics; nickel ion (Ni2+); protein–metabolite–metabolic pathway network; proteomics
Year: 2022 PMID: 35812349 PMCID: PMC9258689 DOI: 10.1093/rb/rbac040
Source DB: PubMed Journal: Regen Biomater ISSN: 2056-3426
Figure 1.Number of differentially expressed proteins in the L929 cells treated with 100 μM Ni2+ for 12, 24 and 48 h.
Figure 2.Number of differentially abundant metabolites in the L929 cells treated with 100 μM Ni2+ for 12, 24 and 48 h.
Metabolic pathways in which proteins and metabolites had upstream and downstream relationships in the Ni2+-12 h, Ni2+-24 h and Ni2+-48 h groups
| Type | Pathways | Ni2+-12 h | Ni2+-24 h | Ni2+-48 h |
|---|---|---|---|---|
| Pathways common to all three time points | 1) Glutathione metabolism | √ | √ | √ |
| 2) Arginine and proline metabolism | √ | √ | √ | |
| 3) Glycerophospholipid metabolism | √ | √ | √ | |
| Pathways common to two time points | 1) Cysteine and methionine metabolism | √ | √ | |
| 2) Alanine, aspartate and glutamate metabolism | √ | √ | ||
| 3) Arginine biosynthesis | √ | √ | ||
| 4) Citrate cycle (TCA cycle) | √ | √ | ||
| 5) D-glutamine and D-glutamate metabolism | √ | √ | ||
| 6) Fructose and mannose metabolism | √ | √ | ||
| 7) Galactose metabolism | √ | √ | ||
| 8) Glycerolipid metabolism | √ | √ | ||
| 9) Glyoxylate and dicarboxylate metabolism | √ | √ | ||
| 10) Histidine metabolism | √ | √ | ||
| 11) Nitrogen metabolism | √ | √ | ||
| 12) Pantothenate and CoA biosynthesis | √ | √ | ||
| 13) Phenylalanine metabolism | √ | √ | ||
| 14) Phenylalanine, tyrosine and tryptophan biosynthesis | √ | √ | ||
| 15) Pyrimidine metabolism | √ | √ | ||
| 16) Tyrosine metabolism | √ | √ | ||
| 17) Valine, leucine and isoleucine biosynthesis | √ | √ | ||
| 18) Valine, leucine and isoleucine degradation | √ | √ | ||
| Pathways appear at one time point | 1) Glycine, serine and threonine metabolism | √ | ||
| 2) Inositol phosphate metabolism | √ | |||
| 3) One carbon pool by folate | √ | |||
| 4) Phosphatidylinositol signalling system | √ | |||
| 5) Beta-alanine metabolism | √ | |||
| 6) Purine metabolism | √ | |||
| 7) Sphingolipid metabolism | √ | |||
| 8) Biosynthesis of unsaturated fatty acids | √ | |||
| 9) Primary bile acid biosynthesis | √ | |||
| 10) Butanoate metabolism | √ | |||
| 11) Synthesis and degradation of ketone bodies | √ | |||
| 12) Pentose phosphate pathway | √ | |||
| 13) Propanoate metabolism | √ |
Metabolic pathways in which proteins and metabolites had upstream and downstream relationships common to all three Ni2+-treated groups
| No. | Pathway | Ni2+-12h | Ni2+-24h | Ni2+-48h | |||
|---|---|---|---|---|---|---|---|
| Protein | Metabolite | Protein | Metabolite | Protein | Metabolite | ||
| 1 | Glutathione metabolism pathway |
|
|
| L-glutamate↓ |
|
|
| Srm↓ | Spermidine↓ |
|
| ||||
| 2 | Arginine and proline metabolism pathway | Srm↓ | Spermidine↓ | 4 (Aldh18a1↓, Lap3↓, Pycrl↓, Pycr2↓) | L-glutamate↓ |
|
|
|
|
| ||||||
| 3 | Glycerophospholipid metabolism pathway | Lpin3↓ | Acetylcholine chloride↓ | 8 (Agpat3↓, Gpd1↓, Gpd1l↓, Gpd2↓, Lpcat3↓, Lpin3↓, Pcyt1a↓, Pisd↓) | PE(36:6) ↑ | 8 (Agpat3↓, Gpd1↓, Gpd1l↓, Gpd2↓, Lpcat3↓, Lpin3↓, Pcyt2↓, Pisd↓) | PE(36:6) ↓ PC(28:0) ↓ |
| 7 (Gpd1↓, Gpd2↓, Gpd1l↓, Lpcat3↓, Lpin3↓, Pcyt1a↓, Pisd↓) | LysoPC(22:5) ↓ | ||||||
Figure 3.The protein–metabolite–metabolic pathway in the interaction between Ni2+ and L929 cells included 24 upstream proteins, 5 downstream metabolites and 2 metabolic pathways.
Figure 4.Glutathione metabolic pathway [22] and the included differentially expressed proteins and metabolites with upstream and downstream relationships in the Ni2+-treated groups.
Figure 5.Arginine and proline metabolic pathway [22] and the differentially expressed proteins and metabolites with upstream and downstream relationships in the Ni2+-treated groups.
Classification of 10 upstream differentially expressed proteins
| Type | Protein |
|---|---|
| Glutathione reductase | 1 (Gsr) |
| Glutathione S-transferases | 4 (Gstm1, Gstm2, Gsto1, Gstp1) |
| Glutathione peroxidase | 2 (Gpx4, Gpx7) |
| Glutamate-cysteine ligase | 1 (Gclm) |
| Isocitrate dehydrogenase | 2 (Idh1, Idh2) |
Figure 6.Images of stained L929 cells in the control group and the 100 μM Ni2+-treated groups.
Figure 7.Average fluorescence intensity of ethidium bromide in the L929 cells in the control groups and the 100 μM Ni2+-treated groups. **P < 0.01 indicates a very significant difference from the control group.
Figure 8.Ratio of GSSG to GSH in the L929 cells in the control groups and the 100 μM Ni2+-treated groups. **P < 0.01 indicates a very significant difference from the control group.
Figure 9.The ATP content in the L929 cells in the control groups and 100 μM Ni2+-treated groups. **P < 0.01 indicates a very significant difference from the control group.
Figure 10.Results of the MMP of the L929 cells in the control groups and 100 μM Ni2+-treated groups. *P < 0.05 indicates a significant difference from the control group. Red fluorescence indicates cells with a normal MMP, and green fluorescence indicates cells with a reduced MMP.
Figure 11.Mechanism of the effect of Ni2+ on L929 cells based on integrative analysis of proteomics and metabolomics.